Valuation: Amgen Inc.

Market Cap 198B 173B 160B 148B 281B 18,770B 285B 1,913B 744B 9,264B 742B 726B 32,018B P/E 2026 *
24x
P/E 2027 * 22x
Enterprise Value 240B 210B 193B 179B 340B 22,732B 345B 2,316B 901B 11,219B 899B 880B 38,776B EV / Sales 2026 *
6.34x
EV / Sales 2027 * 6.04x
Free-Float
99.78%
Yield 2026 *
2.75%
Yield 2027 * 2.91%
1 day+0.45%
1 week+1.65%
Current month+1.65%
1 month+6.47%
3 months+8.26%
6 months+7.74%
Current year+12.46%
1 week 357.89
Extreme 357.89
375.25
1 month 334.05
Extreme 334.0501
375.25
Current year 318.21
Extreme 318.21
391.29
1 year 269.77
Extreme 269.77
391.29
3 years 218.61
Extreme 218.61
391.29
5 years 198.64
Extreme 198.64
391.29
10 years 133.64
Extreme 133.64
391.29
Manager TitleAgeSince
Chief Executive Officer 63 2012-04-30
Director of Finance/CFO 62 2010-05-12
Director of Finance/CFO 67 2019-12-31
Director TitleAgeSince
Chairman 63 2012-12-31
Director/Board Member 65 2011-12-31
Director/Board Member 71 2011-12-31
Date Insider Type Main position Quantity % Market Cap.
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.45%+1.65%+25.65%+68.35% 198B
+2.96%+3.01%+59.87%+173.31% 1,070B
+3.05%+5.23%+72.11%+67.81% 624B
-0.04%+1.20%+35.72%+87.93% 450B
+2.14%-2.07%+27.62%+22.57% 328B
+1.36%+0.17%+29.90%+49.33% 284B
+1.98%+4.08%-25.78%-39.02% 217B
+5.21%+7.93%+21.99%+83.23% 161B
+1.48%-0.04%-4.64%-32.25% 135B
-1.39%+5.14%+13.68%+54.43% 134B
Average +1.85%+1.35%+25.61%+53.57% 360.19B
Weighted average by Cap. +2.22%+0.94%+40.79%+86.12%

Financials

2026 *2027 *
Net sales 37.79B 33.07B 30.48B 28.25B 53.63B 3,587B 54.49B 365B 142B 1,770B 142B 139B 6,118B 38.74B 33.9B 31.25B 28.96B 54.98B 3,677B 55.86B 375B 146B 1,815B 145B 142B 6,272B
Net income 8.23B 7.2B 6.64B 6.15B 11.68B 781B 11.87B 79.6B 30.96B 386B 30.9B 30.23B 1,333B 8.86B 7.76B 7.15B 6.63B 12.58B 841B 12.78B 85.73B 33.34B 415B 33.28B 32.56B 1,435B
Net Debt 41.74B 36.53B 33.66B 31.2B 59.23B 3,961B 60.18B 404B 157B 1,955B 157B 153B 6,757B 36.13B 31.61B 29.14B 27B 51.26B 3,429B 52.09B 349B 136B 1,692B 136B 133B 5,849B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
26-07-07 $368.10 +0.45% 1,940,842
26-07-06 $366.44 -2.06% 2,838,007
26-07-02 $374.15 +3.55% 2,487,837
26-07-01 $361.33 -0.22% 2,244,791
26-06-30 $362.12 +0.44% 2,246,908
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
366.44USD
Average target price
355.21USD
Spread / Average Target
-3.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock